Status:
RECRUITING
Trans-coronary Cooling and Dilution for Cardioprotection During Revascularisation for ST-elevation Myocardial Infarction
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Myocardial Infarction
Reperfusion Injury, Myocardial
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A heart attack (myocardial infarction) occurs when an artery supplying blood to the heart is suddenly blocked resulting in damage to the heart muscle. Patients presenting to hospital with a heart att...
Detailed Description
The study population will comprise 60 patients with ST-Elevation Myocardial Infarction (STEMI) presenting to Harefield Hospital undergoing primary percutaneous coronary intervention (PCI). The primar...
Eligibility Criteria
Inclusion
- Clinical ST-elevation myocardial infarction or equivalent (e.g. new onset LBBB)
- \<12 Hrs after symptom onset
- Thrombolysis in myocardial infarction (TIMI) 0-1 coronary flow in a target vessel
Exclusion
- History of severe asthma
- Pregnancy
- Severe concomitant disease or conditions with a life expectancy of less than one year.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06128993
Start Date
November 1 2023
End Date
January 1 2026
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harefield Hospital
Uxbridge, United Kingdom, UB9 6JH